Vivos Therapeutics Stock (NASDAQ:VVOS)
Previous Close
$0.70
52W Range
$0.55 - $7.95
50D Avg
$0.88
200D Avg
$2.00
Market Cap
$3.76M
Avg Vol (3M)
$1.44M
Beta
6.08
Div Yield
-
VVOS Company Profile
Vivos Therapeutics, Inc. is a medical technology enterprise dedicated to developing and commercializing advanced treatment solutions for adults facing conditions like dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. The company's flagship product, the Vivos System, offers a unique multi-disciplinary therapy that stands out for being non-invasive, non-surgical, and free of pharmaceuticals, specifically addressing these dentofacial and sleep-related issues. Additionally, Vivos Therapeutics provides the VivoScore Program, a service encompassing comprehensive screening and convenient home sleep tests for both adults and children. The Vivos System is distributed and sold to licensed medical professionals, primarily general dentists, across the United States and Canada. Founded in 2016, Vivos Therapeutics, Inc. maintains its headquarters in Highlands Ranch, Colorado.
VVOS Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Treatment Centers | $2.18M | - | - |
| Service | $10.96M | $7.16M | - |
| Product | $6.49M | $7.87M | - |
| Billing Intelligence Services | $686.00K | $840.00K | - |
| Appliances | $3.28M | $5.60M | - |
| VIP | $491.00K | $2.48M | - |
| Sponsorship Seminar Other | $1.22M | $1.94M | - |
| Center Revenue | - | - | $189.00K |
Fiscal year ends in Dec 25 | Currency in USD